Skip to content
Triangle logo TriangleGet started
← Full study record

NCT05091567 · BASELINE

Baseline characteristics

A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer · Source last updated 2026-09-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      241
    2. group Id
      BG001
      value
      242
    3. group Id
      BG002
      value
      483
    units
    Participants
groups
  1. description
    Participants received atezolizumab, 1200 mg, Q3W as IV infusion on Day 1 of each 21-day cycle until unacceptable toxicity or PD whichever occurred first.
    id
    BG000
    title
    Atezolizumab
  2. description
    Participants received atezolizumab, 1200 mg, Q3W, as IV infusion and lurbinectedin, 3.2 mg/m\^2, Q3W, as IV infusion on Day 1 of each 21-day cycle until unacceptable toxicity or PD whichever occurred first.
    id
    BG001
    title
    Atezolizumab+ Lurbinectedin
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          8.0
          value
          66.0
        2. group Id
          BG001
          spread
          7.6
          value
          65.1
        3. group Id
          BG002
          spread
          7.8
          value
          65.5
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          90
        2. group Id
          BG001
          value
          91
        3. group Id
          BG002
          value
          181
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          151
        2. group Id
          BG001
          value
          151
        3. group Id
          BG002
          value
          302
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          16
        2. group Id
          BG001
          value
          16
        3. group Id
          BG002
          value
          32
        title
        Hispanic or Latino
      2. measurements
        1. group Id
          BG000
          value
          210
        2. group Id
          BG001
          value
          206
        3. group Id
          BG002
          value
          416
        title
        Not Hispanic or Latino
      3. measurements
        1. group Id
          BG000
          value
          15
        2. group Id
          BG001
          value
          20
        3. group Id
          BG002
          value
          35
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Ethnicity (NIH/OMB)
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          1
        title
        American Indian or Alaska Native
      2. measurements
        1. group Id
          BG000
          value
          31
        2. group Id
          BG001
          value
          31
        3. group Id
          BG002
          value
          62
        title
        Asian
      3. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Native Hawaiian or Other Pacific Islander
      4. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          3
        3. group Id
          BG002
          value
          4
        title
        Black or African American
      5. measurements
        1. group Id
          BG000
          value
          199
        2. group Id
          BG001
          value
          195
        3. group Id
          BG002
          value
          394
        title
        White
      6. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        More than one race
      7. measurements
        1. group Id
          BG000
          value
          10
        2. group Id
          BG001
          value
          12
        3. group Id
          BG002
          value
          22
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race (NIH/OMB)
    unit Of Measure
    Participants
population Description
Full Analysis Set (FAS) included all participants randomized into the randomized phase, regardless of whether or not the assigned study treatment was received. Analysis was performed on the randomized treatment arms.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      241
    2. group Id
      BG001
      value
      242
    3. group Id
      BG002
      value
      483
    units
    Participants
groups
  1. description
    Participants received atezolizumab, 1200 mg, Q3W as IV infusion on Day 1 of each 21-day cycle until unacceptable toxicity or PD whichever occurred first.
    id
    BG000
    title
    Atezolizumab
  2. description
    Participants received atezolizumab, 1200 mg, Q3W, as IV infusion and lurbinectedin, 3.2 mg/m\^2, Q3W, as IV infusion on Day 1 of each 21-day cycle until unacceptable toxicity or PD whichever occurred first.
    id
    BG001
    title
    Atezolizumab+ Lurbinectedin
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          8.0
          value
          66.0
        2. group Id
          BG001
          spread
          7.6
          value
          65.1
        3. group Id
          BG002
          spread
          7.8
          value
          65.5
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          90
        2. group Id
          BG001
          value
          91
        3. group Id
          BG002
          value
          181
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          151
        2. group Id
          BG001
          value
          151
        3. group Id
          BG002
          value
          302
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          16
        2. group Id
          BG001
          value
          16
        3. group Id
          BG002
          value
          32
        title
        Hispanic or Latino
      2. measurements
        1. group Id
          BG000
          value
          210
        2. group Id
          BG001
          value
          206
        3. group Id
          BG002
          value
          416
        title
        Not Hispanic or Latino
      3. measurements
        1. group Id
          BG000
          value
          15
        2. group Id
          BG001
          value
          20
        3. group Id
          BG002
          value
          35
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Ethnicity (NIH/OMB)
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          1
        title
        American Indian or Alaska Native
      2. measurements
        1. group Id
          BG000
          value
          31
        2. group Id
          BG001
          value
          31
        3. group Id
          BG002
          value
          62
        title
        Asian
      3. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Native Hawaiian or Other Pacific Islander
      4. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          3
        3. group Id
          BG002
          value
          4
        title
        Black or African American
      5. measurements
        1. group Id
          BG000
          value
          199
        2. group Id
          BG001
          value
          195
        3. group Id
          BG002
          value
          394
        title
        White
      6. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        More than one race
      7. measurements
        1. group Id
          BG000
          value
          10
        2. group Id
          BG001
          value
          12
        3. group Id
          BG002
          value
          22
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race (NIH/OMB)
    unit Of Measure
    Participants
population Description
Full Analysis Set (FAS) included all participants randomized into the randomized phase, regardless of whether or not the assigned study treatment was received. Analysis was performed on the randomized treatment arms.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice